First North Announcement no. 7 2007/ 7th May, 2007
Copenhagen, 7th May, 2007
Summary: The Danish Working Environment Authority has today approved Aresa's
application for testing of genetically modified Thale cress.
Aresa receives GMO approval.
On March 30th 2006 Aresa applied to the Danish Environmental Agency (Skov- og
Naturstyrelsen) for release of genetically modified Thale cress. The Thale cress
plant is to be used for detection of explosives in soil, e.g. landmines. The
Environmental Agency and The Danish Working Environment Authority has evaluated
and approved Aresa's GMO application in accordance with the ministry's executive
order No. 642 of 28th june 2001 concerning gene-technology and working
environment.
The testing will take place at an enclosed test site in Jægerspris, Denmark and
will be initiated within the coming weeks and will continue throughout the
growing season 2007. In order to obtain most possible test data, Aresa will test
several genetic variations combined with various eco-types of Thale cress
(Arabidopsis thaliana).
“This approval is another significant milestone in Aresas continued development
of the landmine detecting plant RedDetect™ and is another step towards our aim
of becoming a sustainable Plant Biotechnological company over the coming years”
states CEO Jarne Elleholm.
The content of this message is not expected to have impact on the result for the
current financial year.
Best regards,
Jarne Elleholm
CEO
Aresa A/S
Further information can be obtained by contacting Jarne Elleholm, CEO for Aresa
A/S on +45 70227747, mobile: +45 41190136 or to the company's financial advisor
HSH Gudme Corporate Finance A/S, Morten Kjærulff, Director, +45 33449431.
About Aresa
Aresa is a plant biotech company established in 2001 by the company's current
CSO, Carsten Meier and has origins from the Institute of Molecular Biology at
Copenhagen University.
Aresa has developed two plant based technology platforms, BioSensor for the
detection of substances in soil, hereunder evaporation of explosives from
landmines; and BioPharma, a tool for the optimisation and production of
antibodies and proteins in plants.
Aresa was listed on the Copenhagen OMX-First North market place in 2006. Aresa
is based at Symbion Science Park in Copenhagen and has greenhouse facilities in
the outskirts of Copenhagen and test areas in Denmark, Croatia and in Bosnia
Herzegovina. Aresa has 16 employees, hereof 8 within research and development
and 5 within landmine operations.
